Drug prescription pattern in asthma in a tertiary care hospital in South India

Sruthi Sethumadhavan; Kala Kesavan Parvathy; Shajahan Purathel Sulaiman

doi:10.18203/2319-2003.ijbcp20243833

Authors

Sruthi Sethumadhavan Department of Pharmacology, Sree Balaji Medical College and Hospital Chennai, Tamil Nadu, India
Kala Kesavan Parvathy Department Of Pharmacology, Govt. T.D. Medical College, Alappuzha, Kerala, India
Shajahan Purathel Sulaiman Department Of Pulmonary Medicine, Govt. T.D. Medical College, Alappuzha, Kerala, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20243833

Keywords:

Asthma, Prescription pattern monitoring studies, Co-morbidities, WHO essential drug list, NLEM

Abstract

Background: Asthma, a chronic inflammatory disorder of the airways, affecting millions of individuals is a global health concern. It necessitates long-term management for optimal outcomes. impacting therapy costs and patient’s compliance. This study was done to analyse current prescribing trends in the management of asthma patients. This study examines current asthma treatment trends to enhance patient care and disease outcomes.

Methods: This is an Observational cross-sectional study conducted at Government T. D. medical college, Alappuzha between October 2019 to September 2022. All patients clinically diagnosed with or a previously known case of asthma between 18-60 years of both sex attending the outpatient department of Pulmonary Medicine who gave consent for study were included. Data was collected by interviewing and from the patients OP card using a prestructured proforma. Data collected included patient details, allergy and smoking history, comorbid conditions, drugs prescribed for asthma along with dose, route and frequency of administration, concomitant medications, diagnostic tests if any.

Results: Out of 200 asthma cases, 119 (59.5%) were females. The mean age was 43.95±10.62 years. 21 patients (10.5%) were smokers. 57 (28.5%) patients had an allergic predisposition. Hypertension n=48 (24%) was the most common comorbidity among the patients. A mean of 3.05±1.52 drugs per prescription. Out of 609 drugs prescribed, 450 (73.89%) drugs were from the National list of essential medicines (NLEM) and 366 (60.09%) drugs were from the WHO essential list. A combination of LABA with ICS was the most common drug given in 121 (60.5%) patients followed by Glucocorticoids 101 (50.5%) and PDE-inhibitor-Deriphylline 74 (37%) patients. Antibiotics was prescribed in 43 (21.5%) patients. 164 (82%) patients received a combination therapy. Out of the 609 drugs prescribed, 334 (54.8%) were oral followed by inhalational route 264 (43.3%).

Conclusion: Study demonstrates the variability of drug utilization in asthma patients. The rising significance of PPMS (Prescription pattern monitoring studies) stems from heightened marketing of new medications, shifts in prescribing patterns and drug consumption, escalating worries regarding delayed adverse reactions, drug costs, and prescription volumes.

Metrics

Metrics Loading ...

References

Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbio. 2013;4:1–16.

Mcdonald VM, Gibson PG, Maltby S, King GRG, James ALAN, et al; Seeking innovative solutions in severe asthma. Respirol. 2016;22(1):19-20

Longo, Fauci, Kasper, Hauser, Jameson, Loscalzo; Harrison's manual of Medicine. 18th edi. McGraw Hill; 2012: 907-910.

Global initiative for asthma. Global strategy for asthma management and prevention. 2020. Available at: www.ginasthma.org. Accessed on 15 July 2024.

Pandey A, Tripathi P, Pandey R. Prescription pattern in asthma therapy at Gorakhpur hospitals. Lung India. 2010;27(1):8–10.

Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med. 2010;35(1):10–3.

Jain S, Jain P, Moghe V, Seth V, Upadhyaya P, Abhijit K, et al. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Persp Clin Res. 2015;6(2):86.

Trivedi N, Acharya HR, Barvaliya MJ, Tripathi CB. Prescribing pattern in patients of asthma visiting outpatient departments of a tertiary care hospital: a cross-sectional, observational study. Int J Basic Clin Pharmacol. 2017;6(3):587.

Baldaçara RP de C, Silva I. Association between asthma and female sex hormones. Sao Paulo Med J. 2017;135(1):4–14.

Macsali F, Real FG, Omenaas ER, Bjorge L, Janson C, Franklin K, et al. Oral contraception, body mass index, and asthma: A cross-sectional Nordic-Baltic population survey. J All Clin Immunol. 2009;123(2):391–7.

Tiotiu A, Ioan I, Wirth N, Romero-Fernandez R, González-Barcala FJ. The impact of tobacco smoking on adult asthma outcomes. Int J Environ Res & Public Heal. 2021;18(3):1–12.

George M, Joseph L, Mohan N. Evaluation of drug prescribing pattern in patients with bronchial asthma. Europ J Pharm Med Res. 2017;4(9):702-6.

Ferguson S, Teodorescu MC, Gangnon RE, Peterson AG, Consens FB, Chervin RD, et al. Factors associated with systemic hypertension in asthma. Lung. 2014;192(5):675–83.

Bragina EY, Goncharova IA, Garaeva AF, Nemerov E V., Babovskaya AA, Karpov AB, et al. Molecular relationships between bronchial asthma and hypertension as comorbid diseases. J Integrr Bioinform. 2018;15(4):53-9.

Sharad Karki, Ipseeta Ray Mohanty, Pradip V. Potdar, YA Deshmukh, RC Shah, BR Pokhrel. Assessment of prescribing patterns of drugs used in adult asthma patients at a tertiary care hospital. Int J Curr Res Med Sci. 2017;3(6):169–75.

Rafeeq MM, Murad HAS. Evaluation of drug utilization pattern for patients of bronchial asthma in a government hospital of Saudi Arabia. Niger J Clin Pract. 2017;20(9):1098–105.

Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Maier S, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: Data from a randomized controlled trial. Respir Res. 2018:1;19.

Garje YA, Kumar SR, Kumar R, Deshmukh Y, Patra V, Suman et al. Prescribing patterns and pharmacoeconomic analysis of drugs used in pediatric asthma patients at tertiary care hospital. World J Pharma Pharma Sci. 2014:3(6);1448-65.

Devillier P, Humbert M, Boye A, Zachgo W, Jacques L, Nunn C, et al. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Resp Med. 2018;141:111–20.

Jenkins CR, Bateman ED, Sears MR, O’Byrne PM. What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever? Respirology; 2020;25:804–15.

Jayadeva BT, Panchaksharimath P. A retrospective study on drug utilization in patients with acute exacerbation of bronchial asthma in adults at a tertiary teaching hospital in Bengaluru. Egypt J Chest Dis Tuberc. 2016;65(1):19–22.

Ramadan AA, Gaffin JM, Israel E, Phipatanakul W. Asthma and corticosteroid responses in childhood and adult asthma. Clin Chest Med. 2019;2:163–77.

Maselli DJ, Peters JI. Medication regimens for managing acute asthma. Respiratory Care. 2018;63(6):783–96.

Kaplan A, Mitchell PD, Cave AJ, Gagnon R, Foran V, Ellis AK. Effective Asthma Management: Is It Time to Let the AIR out of SABA? J Clin Med. 2020;9(4):921.

Kirkland SW, Vandenberghe C, Voaklander B, Nikel T, Campbell S, Rowe BH. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. Cochr Data Sys Rev. 2017;6(1):465060.

Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, Lopez-Verde F, Pico-Soler V, Leiva- Fernandez F, et al. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study. PLoS One. 2020;(15):1–20.

Saji M, Elizabeth Raju L, Thomas SP, Manna PK, Ramesh S, Author C, et al. Study of drug prescribing and use pattern in paediatric bronchial asthma patients. Int J Adv Res. 2017;5(7):691–8.